MedTrace Logo

Cardioversion vs. Catheter Ablation for Persistent Atrial Fibrillation

NCT00196209 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2008-03-19

No results posted yet for this study

Summary

The aim of this randomized study is to evaluate the efficacy of two different approaches for conversion of persistent atrial fibrillation, the non-invasive one (external electrical cardioversion) and the invasive one (catheter ablation).

Conditions

Interventions

PROCEDURE

catheter ablation

catheter ablation to treat persistent atrial fibrillation

PROCEDURE

external electric cardioversion

external cardioversion and drug prophylaxis to treat persistent atrial fibrillation

Sponsors & Collaborators

  • Deutsches Herzzentrum Muenchen

    lead OTHER

Principal Investigators

  • Isabel Deisenhofer, MD · Deutsches Herzzentrum Muenchen

  • Heidi L Estner, MD · Deutsches Herzzentrum Muenchen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2009-06-30
Completion
2009-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00196209 on ClinicalTrials.gov